G6PC1 and Hyperglycemia: Reinforcing these findings, glucagon receptor-knockout male and female C57BL/6J mice were protected against olanzapine (5 mg/kg, i.p.)-induced hyperglycemia in an acute study (120 min), in association with reduced protein content of PEPCK and glucose-6-phosphatase (G6Pase) in the liver [103].